Patricia Niccoli
Marseille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Predictive factors for persistent thrombocytopenia after peptide receptor radioligand therapy in enteropancreatic neuroendocrine tumors.
Journal: Frontiers in endocrinology
Published: January 29, 2025
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 25, 2024
Genetic testing in prolactinomas: a cohort study.
Journal: European journal of endocrinology
Published: June 22, 2023
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial.
Journal: Lancet (London, England)
Published: June 17, 2023
Outcome of nonfunctioning pancreatic neuroendocrine tumors after initial surveillance or surgical resection: a single-center observational study.
Journal: Annals of gastroenterology
Published: January 28, 2023
Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial.
Journal: The Lancet. Oncology
Published: November 22, 2022
Transarterial chemoembolization (TACE) for neuroendocrine liver metastasis (NELM): Predictive value of volumetric arterial enhancement (VAE) on baseline MRI.
Journal: Bulletin du cancer
Published: September 15, 2022
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial.
Journal: The British journal of surgery
Published: March 21, 2022
Pasireotide for Refractory Hypoglycemia in Malignant Insulinoma- Case Report and Review of the Literature.
Journal: Frontiers in endocrinology
Published: January 23, 2022
Intermittent versus continuous administration of pazopanib in progressive radioiodine refractory thyroid carcinoma: Final results of the randomised, multicenter, open-label phase II trial PAZOTHYR.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 09, 2021
Efficacy of FOLFOX Chemotherapy in Metastatic Enteropancreatic Neuroendocrine Tumors.
Journal: Anticancer research
Published: February 15, 2021
Last Updated: 09/26/2026